Edition:
United States

Circassia Pharmaceuticals PLC (CIRCI.L)

CIRCI.L on London Stock Exchange

87.00GBp
19 Oct 2017
Change (% chg)

1.25 (+1.46%)
Prev Close
85.75
Open
85.00
Day's High
87.00
Day's Low
84.50
Volume
43,054
Avg. Vol
248,075
52-wk High
114.00
52-wk Low
76.75

Chart for

About

Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve... (more)

Overall

Beta: -0.58
Market Cap(Mil.): £283.14
Shares Outstanding(Mil.): 333.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 64.72 16.24
EPS (TTM): -- -- --
ROI: -- -0.89 10.90
ROE: -- -0.15 14.09

BRIEF-Circassia Pharmaceuticals says H1 revenues up 65 pct to 18.3 mln pounds

* H1 REVENUE OF 18.3 MILLION STG VERSUS 11.1 MILLION STG YEAR AGO

Sep 27 2017

BRIEF-Circassia Pharma says Duaklir improves lung function in COPD patients

* Announces duaklir® successfully met primary endpoints in amplify phase iii study in chronic obstructive pulmonary disease

Sep 07 2017

BRIEF-Circassia Pharmaceuticals fy revenues increased to 23.1 mln stg

* FY revenues increased to £23.1 million (2015: £10.8 million)

Apr 25 2017

Earnings vs. Estimates